Greater fractalkine expression in mesenteric arteries of female spontaneously hypertensive rats compared with males

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 4, 2009, Pages

  Sullivan, Jennifer C ^a   Pardieck, Jennifer L ^a   Doran, Derek ^a   Zhang, Yan ^a   She, Jin Xiong ^a   Pollock, Jennifer S ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Hypertension; Inflammation; Microarray; Sex difference; Tumor necrosis factor

Indexed keywords

ACETYLCHOLINE; FRACTALKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; POTASSIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HYPERTENSION; MALE; MESENTERIC ARTERY; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; URINARY EXCRETION; WESTERN BLOTTING;

ACETYLCHOLINE; ANIMALS; CHEMOKINE CCL2; CHEMOKINE CX3CL1; DISEASE MODELS, ANIMAL; FEMALE; HYPERTENSION; MALE; MESENTERIC ARTERIES; NITROPRUSSIDE; PHENYLEPHRINE; POTASSIUM CHLORIDE; RATS; RATS, INBRED SHR; SEX CHARACTERISTICS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS;

EID: 66249121416     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01093.2008     Document Type: Article

References (40)

1. Ahn S, Cho C, Park K, Lee H, Lee S, Park S, Lee I, Koh GY. Tumor necrosis factor-α induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-a-induced fractalkine expression. Am J Pathol 164: 1663-1672, 2004.
2. Arenas IA, Armstrong SJ, Xu Y, Davidge ST. Chronic tumor necrosis factor-α inhibition enhances NO modulation of vascular function in estrogen-deficient rats. Hypertension 46: 76-81, 2005.
3. Balabanian K, Foussat A, Dorfmuller P, Durand-Gasselin I, Capel F, Bouchet-Delbos L, Portier A, Marfaing-Koka A, Krysiek R, Rimaniol A, Simonneau G, Emilie D, Humbert M. CX3C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 165: 1419-1425, 2002.
4. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens 19: 149-154, 2005.
5. 3C motif. Nature 385: 640-644, 1997.
6. 3CL1) stimulated by nuclear factor kappa B (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem J 373:547-558, 2003.
7. 3CR1/apoliporpotein E double knockout mice. Circulation 107: 1009-1016, 2003.
8. Cook DN, Chen SC, Sullivan LM, Manfra DJ, Wiekowski MT, Prosser DM, Vassileva G, Lira SA. Generation and analysis of mice lacking the chemokine fractalkine. Mol Cell Biol 21: 3159-3165, 2001.
9. 3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 188: 1413-1419, 1998.
10. Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, Raines EW. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 276: 37993-38001, 2001.
11. Ishibashi M, Hiasa K, Zhao Q, Inoue S, Ohtani K, Kitamoto S, Tsuchihashi M, Sugaya T, Charo IF, Kura S, Tsuzuki T, Ishibashi T, Takeshita A, Egashira K. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circ Res 94: 1203-1210, 2004.
12. Känen M, Tolvanen JP, Sallinen K, Wu X, Pörsti I. Influence of gender on control of arterial tone in experimental hypertension. Am J Physiol Heart Circ Physiol 275: H15-H22, 1998.
13. Kampus P, Muda P, Kals J, Ristimae T, Fischer K, Teesalu R, Zilmer M. The relationship between inflammation and arterial stiffness in patients with essential hypertension. Int J Cardiol 112: 46 -51, 2006.
14. Kauser K, Rubanyi GM. Gender differences in endothelial dysfunction in the aorta of spontaneously hypertensive rats. Hypertension 25: 517-523, 1995.
15. Kim HY, Kang YJ, Song IH, Choi HC, Kim HS. Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertens Res 31: 515-523, 2008.
16. Kongshavn PA, Bliss JQ. Sex differences in survival of H-2 incompatible skin grafts in mice treated with antithymocyte serum. Nature 226: 451, 1070.
17. Lehman TJ, Curd JG, Zvaifler NJ, Hanson V. The association of antinuclear antibodies, antilymphocyte antibodies, and C4 activation among relatives of children with systemic lupus erythematosus. Arthritis Rheum 25: 556-561, 1982.
18. -/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 111: 333-340, 2003.
19. 3CR1 deficiency confers protection from intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol 26: 2056-2062, 2006.
20. 3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 111: 1241-1250, 2003.
21. 3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res 89: 401-407, 2001.
22. 3CR1 as a genetic risk factor for coronary artery disease. Blood 97: 1925-1928, 2001.
23. Nevala R, Vaskonen T, Vehniainen J, Korpela R, Vapaatalo H. Soy based diet attenuates the development of hypertension when compared to casein based diet in spontaneously hypertensive rats. Life Sci 66: 115-124, 2000.
24. 3CR1) inhibition is protective against ischemic acute renal failure in mice. Am J Physiol Renal Physiol 294: F264-F271, 2008.
25. Parissis JT, Korovesis S, Giazitzoglou E, Kalivas P, Katritus D. Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1. Int J Cardiol 83: 13-21, 2002.
26. A receptor antagonists, candesartan, and A-127722 in DOCA-salt hypertensive rats. Gen Pharmacol 34: 337-342, 2000.
27. Savoia C, Schiffrin E. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond) 112: 375-384, 2007.
28. 3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions. Arterioscler Thromb Vasc Biol 27: 55-62, 2007.
29. Schuurs AH, Verheul HA. Effects of gender and sex steroids on the immune response. J Steroid Biochem 35: 157-172, 1990.
30. Sullivan JC, Loomis ED, Collins MH, Imig JD, Inscho EW, Pollock JS. Age-related alterations in NOS and oxidative stress in mesenteric arteries from male and female rats. J Appl Physiol 97: 1268 -1274, 2004.
31. Sullivan JC, Pollock DM, Pollock JS. Altered nitric oxide synthase 3 distribution in mesenteric arteries of hypertensive rats. Hypertension 39:597-602, 2002.
32. Sullivan JC, Sasser JM, Pollock DM, Pollock JS. Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats. Hypertension 45: 406-411, 2005.
33. Sullivan JC, Semprun-Prieto L, Boesen EI, Pollock DM, Pollock JS. Sex and sex hormones influence the development of albuminuria and renal macrophage infiltration in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 293: R1573-R1579, 2007.
34. Teupser D, Pavlides S, Tan M, Guitierrez-Ramos J, Kolbeck R, Breslow JL. Major reduction of atherosclerosis in fractalkine (CX3CL1)- deficient mice is at the brachiocephalic artery, not the aortic root. Proc Natl Acad Sci USA 101: 17795-17800, 2004.
35. Tsou CL, Haskell CA, Charo IF. Tumor necrosis factor-a-converting enzyme mediates the inducible cleavage of FKN. J Biol Chem 276:44622-44626, 2001.
36. Umehara H, Goda S, Imai T, Nagano Y, Minami Y, Tanaka Y, Okazaki T, Bloom ET, Domae N. Fractalkine, a CX3C-chemokine, functions predominately as an adhesion molecule in monocytic cell line THP-1. Immunol Cell Biol 79: 298-302, 2001.
37. Vitale S, Schmid-Alliana A, Breuil V, Pomeranz M, Millet M, Rossi B, Schmid-Antomarchi H. Soluble fractalkine prevents monocyte chemoat- tractant protein-1-induced monocyte migration via inhibition of stress- activated protein kinase 2/p38 and matrix metalloproteinase activities. J Immunol 172: 585-592, 2004.
38. 3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc Pathol 11: 332-338, 2002.
39. Yen C, Lau Y. Vascular responses in male and females hypertensive rats with hyperhomocysteinemia. Hypertension 40: 322-328, 2002.
40. Yoneda O, Imai T, Goda S, Inoue H, Yamauchi A, Okazaki T, Imai O, Bloom ET, Domae N, Umehara H. Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 164: 4055-4062, 2000.